Immunovant, Inc.
IMVT
$41.82
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 797.80M | 902.11M | 994.53M | 521.87M | 598.91M |
| Total Receivables | 697.00K | 3.95M | 1.64M | 1.97M | 1.94M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 52.68M | 42.76M | 46.77M | 49.71M | 50.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 851.18M | 948.82M | 1.04B | 573.55M | 651.76M |
|
|
|||||
| Total Current Assets | 851.18M | 948.82M | 1.04B | 573.55M | 651.76M |
| Net Property, Plant & Equipment | 351.00K | 515.00K | 531.00K | 632.00K | 737.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 961.00K | 7.68M | 8.92M | 8.78M | 8.94M |
| Total Assets | 852.49M | 957.01M | 1.05B | 582.96M | 661.44M |
|
|
|||||
| Total Accounts Payable | 10.14M | 7.54M | 8.62M | 6.92M | 7.84M |
| Total Accrued Expenses | 64.48M | 96.63M | 57.64M | 55.67M | 44.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 72.00K | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 42.48M | 175.00K | -- | 671.00K | 862.00K |
| Total Other Current Liabilities | 42.48M | 175.00K | -- | 671.00K | 862.00K |
| Total Current Liabilities | 117.10M | 104.42M | 66.26M | 63.25M | 52.90M |
|
|
|||||
| Total Current Liabilities | 117.10M | 104.42M | 66.26M | 63.25M | 52.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 117.10M | 104.42M | 66.26M | 63.25M | 52.90M |
|
|
|||||
| Common Stock & APIC | 2.63B | 2.60B | 2.58B | 2.00B | 1.97B |
| Retained Earnings | -1.90B | -1.75B | -1.60B | -1.49B | -1.36B |
| Treasury Stock & Other | 725.00K | 730.00K | 1.20M | 1.45M | 1.74M |
| Total Common Equity | 735.39M | 852.59M | 986.14M | 519.71M | 608.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 735.39M | 852.59M | 986.14M | 519.71M | 608.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 735.39M | 852.59M | 986.14M | 519.71M | 608.54M |
|
|
|||||